Somatic chromosomal engineering identifies BCAN-NTRK1 as a potent glioma driver and therapeutic target

The widespread application of high-throughput sequencing methods is resulting in the identification of a rapidly growing number of novel gene fusions caused by tumour-specific chromosomal rearrangements, whose oncogenic potential remains unknown. Here we describe a strategy that builds upon recent a...

Descripción completa

Detalles Bibliográficos
Autores principales: Cook, Peter J., Thomas, Rozario, Kannan, Ram, de Leon, Esther Sanchez, Drilon, Alexander, Rosenblum, Marc K., Scaltriti, Maurizio, Benezra, Robert, Ventura, Andrea
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5508201/
https://www.ncbi.nlm.nih.gov/pubmed/28695888
http://dx.doi.org/10.1038/ncomms15987

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5508201/
https://www.ncbi.nlm.nih.gov/pubmed/28695888
http://dx.doi.org/10.1038/ncomms15987

Ejemplares similares